Amyloid formation modulates the biological activity of a bacterial protein

Sylvain Bieler1, Lisbell Estrada, Rosalba Lagos

  • 1Department of Neurology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

Insights

Microcin E492, a bacterial peptide, forms amyloid-like fibrils in vitro and in vivo. This suggests protein aggregation into amyloid fibrils is an evolutionarily conserved property used by bacteria for physiological needs.

Area of Science:

  • Biochemistry
  • Microbiology
  • Structural Biology

Background:

  • Protein aggregation into amyloid fibrils is linked to neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Microcin E492 is a peptide produced by Klebsiella pneumoniae that forms pores in bacterial membranes, exhibiting toxicity.

Purpose of the Study:

  • To investigate the in vitro and in vivo amyloid fibril formation of microcin E492.
  • To compare the properties of microcin E492 amyloid fibrils with those found in human diseases.
  • To explore the physiological role of amyloid formation in bacteria.

Main Methods:

  • In vitro assembly of microcin E492 into amyloid-like fibrils.
  • Characterization of fibril properties (structural, morphological, tinctorial, biochemical).
  • In vivo studies of microcin E492 aggregation and toxicity.

Main Results:

  • Microcin E492 self-assembles into amyloid-like fibrils in vitro with properties similar to disease-associated aggregates.
  • Amyloid formation of microcin E492 was also observed in vivo.
  • In vivo amyloid formation correlated with a loss of microcin E492's toxicity.

Conclusions:

  • Protein aggregation into amyloid fibrils is an evolutionarily conserved mechanism.
  • Bacteria can utilize amyloid formation for specific physiological functions, as exemplified by microcin E492.
  • The study provides insights into the dual nature of protein aggregation, relevant to both disease and bacterial physiology.

Related Concept Videos

Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...